cancer Flashcards
benign tumors general characteristics
Grow slowly
Have a well-defined capsule
Are well differentiated (look like the tissue from which they arose)
Low mitotic index (dividing cells are rare)
Do not metastasize
Suffix “-oma”
malignant tumors general characteristics
Grow rapidly
Are not encapsulated
Are poorly differentiated (may not be able to determine tissue of origin)
High mitotic index (many dividing cells)
Can spread distantly, often through blood vessels and lymphatics
carcinoma
cancers arising from epithelial tissue
adenocarcinoma
cancers arising from ductal or glandular structures
sarcoma
cancers arising from connective tissue (ex. cancer of skeletal muscle are called rhabdomyosarcomas)
lymphoma
cancers of lymphatic tissue
leukemia
cancers of blood forming cells
carcinoma in situ
early stage cancers
preinvasive epithelial tumors of glandular or squamous cell
- localized to epithelium
- haven’t penetrated local basement membrane or invaded surrounding stroma (functional /connective tissue)
often found: cervix, skin, oral cavity, esophagus, bronchus, stomach, endometrium, breast, large bowel
tumor markers
substances produced by both benign & malignant cells
- present in/on tumor cells or are found in blood, spinal fluid, or urine
- substrates including hormones, enzymes, genes, antigens, antibodies
- screen/identify individuals at high risk for cancer
- help diagnose specific types of tumors
- used to follow clinical course of cancer
paraneoplastic syndrome
symptom complexes triggered by a cancer; not caused by direct local effects of tumor mass
caused by biologic substances released from the tumor (e.g., hormones/tumor markers) or by immune response triggered by the tumor
- ex: pheochromocytoma
may be the earliest symptom of a cancer
anaplasia
the absence of differentiation; characterized as a loss of organization and marked increase in nuclear size with evidence of ongoing proliferation
cancer cells don’t acquire specialized function
most common genetic mutation in cancers
point mutation (alteration of one or a few nucleotide base pairs)
chromosomal translocations activate oncogenes 2x ways
- excess production of a proliferative factor
- production of novel proteins with growth promoting properties
point mutation
alteration of one or few nucleotide base pairs → converts from proto-oncogene to unregulated oncogene
= accelerates cell proliferation
gene amplication
over duplication of a gene that increases expression of oncogene
tumor suppressor genes
encode proteins that in their normal state halt proliferation
takes 2 hits to inactivate 2 alleles of tumor-suppressor gene bc alleles act in recessive manner at cellular level
inherited mutations are almost always found in these d/t loss of heterozygosity or epigenetic silencing
epigenetic silencing
normal phenomenon where whole regions of chromosomes are shut off so the pattern of gene expression is different than that seen in other cells with the same genes
- can silence tumor suppressing genes
- contribute to inappropriate expression of oncogenes
caretaker genes
responsible for maintenance of genomic integrity, encode proteins involved in repairing damaged DNA during:
- DNA replication
- mutations d/t ultraviolet or ionizing radiation
- mutations caused by chemicals & drugs
inherited mutations are almost always found where & how
in tumor-suppressor genes by loss of heterozygosity or epigenetic silencing
mutant protein RAS
stimulates cell growth even when growth factors missing
up to 1/3 of all cancers have activating mutation in in gene for intracellular signaling protein RAS
angiogenesis + factors x3
aka neovascularization – ability to secrete factors that stimulate new blood vessel growth
Vascular endothelial growth factor (VEGF)
Platelet derived growth factor (PDGF)
Basic fibroblast growth factor (bFGF)
6 pathways/hallmarks of cancer
- sustained angiogenesis
- tissue invasion and metastasis
- evading apoptosis
- self-sufficiency in growth signal
- insensitivity to anti-growth signals
- limitless replicative potential
HPV + cancer
cervical cancer
vaccines protect against HPV 16 & 18 (causes 70% of cervical cancers) + HPV 6 & 11 (causes 90% of genital warts)
Epstein Barr + cancer
development of B-cell lymphomas (Hodgkin/non-Hodgkin), cancers of nasopharynx
Kaposi sarcoma
occurs in a significantly more virulent form in individuals who are immunocompromised